EDGE-Gastric Arm A1: Phase 2 study of domvanalimab, zimberelimab, and FOLFOX in first-line (1L) advanced gastroesophageal cancer Meeting Abstract
| Authors: | Janjigian, Y. Y.; Oh, D. Y.; Pelster, M.; Wainberg, Z. A.; Sison, E. A. R.; Scott, J. R.; Ronayne, J.; Wishengrad, D.; Rhee, J.; Nuyten, D. S. A.; Rha, S. Y. |
| Abstract Title: | EDGE-Gastric Arm A1: Phase 2 study of domvanalimab, zimberelimab, and FOLFOX in first-line (1L) advanced gastroesophageal cancer |
| Meeting Title: | 2023 ASCO Monthly Plenary Series: November Session |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 36 Suppl. |
| Meeting Dates: | 2023 Nov 7 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-11-03 |
| Language: | English |
| ACCESSION: | WOS:001094769600008 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2023.41.36_suppl.433248 |
| Notes: | Meeting Abstract: 433248 -- Source: Wos |
